These drugs, which are typically prescribed for treating Type 2 Diabetes and Obesity, have a higher value than conventional medications
It may also be related to eating significantly less, dehydration, changes in blood sugar, nausea, or the body adjusting to a new routine
Research supports the rationale for combining TB-500, BPC-157, and GHK-Cu and with each compound contributing mechanistically distinct activity: TB-500 driving systemic angiogenesis and cell migration through actin regulation, BPC-157 providing multi-tissue cytoprotection and growth factor receptor upregulation, and GHK-Cu delivering targeted collagen synthesis stimulation, MMP regulation, and the broad gene expression remodelling programme that characterises its unique biology
While cross-sectional studies show correlations between circadian disruption and age-related diseases, we need more longitudinal studies to determine if circadian improvements can delay the onset of those diseases
These medications are still widely prescribed today and for some patients, they remain a reasonable option